Eli Lilly to sell diabetic nasal drug to Amphastar for $1.07 billion
Eli Lily sold its sugar-controlling drug to Amphastar Pharmaceuticals for $1.07 billion.
Drugs
Health
Pharma
Drugs
Medical
Pharma
Sanofi lowers Lantus insulin costs by 78% in U.S. market
Sanofi, a French pharmaceutical major, announced it would slash the price of insulin, Lantus, by 78% for all U.S. patients with commercial insurance.
Drugs
Pharma
Novo Nordisk follows Eli Lilly on insulin price cuts
Denmark's Novo Nordisk plans to effect a 75% cut in insulin prices in the U.S. market by January 1, 2024.
Drugs
Medical
Pharma
Eli Lilly gets FDA nod for blood cancer drug
Eli Lilly announced that it had received US FDA approval for a tablet to treat a rare form of blood cancer.
Drugs
Pharma
Eli Lilly plans $450 million extra to expand Research Triangle
Eli Lilly will invest an additional $450 million to expand its manufacturing capacity at Research Triangle Park facility in North Carolina.
Drugs
Pharma
California sues insulin makers, PBMs, for skyrocketing prices
https://oag.ca.gov/news/press-releases/attorney-general-bonta-sues-nations-largest-insulin-makers-pharmacy-benefit